These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Intra-arterial thrombolysis in peripheral bypass and arterial occlusions. Results and predictive factors for thrombolysis]. Sandbaek G; Staxrud LE; Rosén L; Bay D; Stiris M; Gjølberg T Tidsskr Nor Laegeforen; 1996 Oct; 116(25):3000-4. PubMed ID: 8975423 [TBL] [Abstract][Full Text] [Related]
9. Comparison of tissue plasminogen activator and urokinase in the local infiltration thrombolysis of peripheral arterial occlusions. Schweizer J; Altmann E; Stösslein F; Florek HJ; Kaulen R Eur J Radiol; 1996 May; 22(2):129-32. PubMed ID: 8793432 [TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator. Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898 [TBL] [Abstract][Full Text] [Related]
11. Results of a recently instituted programme of thrombolytic therapy in acute lower limb ischaemia. Dawson KJ; Reddy K; Platts AD; Hamilton G Br J Surg; 1991 Apr; 78(4):409-11. PubMed ID: 1903317 [TBL] [Abstract][Full Text] [Related]
12. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
15. Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone. Réganon E; Ferrando F; Vila V; Villa P; Martínez-Sales V; Fayos L; Ruano M; Aznar J Haemostasis; 1998; 28(2):99-105. PubMed ID: 10087435 [TBL] [Abstract][Full Text] [Related]
16. [Endovenous thrombolysis in acute myocardial infarct. The experience in a community hospital. An analysis of 120 patients]. Jorge Sdo C Arq Bras Cardiol; 1992 Jul; 59(1):23-30. PubMed ID: 1341143 [TBL] [Abstract][Full Text] [Related]
17. Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis. Ouriel K; Welch EL; Shortell CK; Geary K; Fiore WM; Cimino C J Vasc Surg; 1995 Nov; 22(5):593-7. PubMed ID: 7494361 [TBL] [Abstract][Full Text] [Related]
18. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg; 1994 Sep; 220(3):251-66; discussion 266-8. PubMed ID: 8092895 [TBL] [Abstract][Full Text] [Related]
19. Low dose intra-arterial streptokinase and acylated plasminogen-streptokinase activator complex: a retrospective review of two thrombolytic regimes in recent peripheral arterial ischaemia. Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR Eur J Vasc Surg; 1987 Jun; 1(3):151-8. PubMed ID: 3332631 [TBL] [Abstract][Full Text] [Related]
20. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog. Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]